Literature DB >> 2194462

In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients.

B W Needleman1, J V Ordonez, D Taramelli, W Alms, K Gayer, J Choi.   

Abstract

A subpopulation of scleroderma dermal fibroblasts was identified by flow cytometric analysis. Between 15% and 25% of the cells within the scleroderma fibroblast lines had high levels of cytoplasmic granularity, as identified by side light scatter characteristics. Similar fibroblasts composed less than 3% of the cells within the normal fibroblast lines, although greater numbers could be induced through exposure to soluble factors derived from activated mononuclear cells. The granular subpopulation of fibroblasts produced 2-3 times as much procollagen as did the other fibroblasts. These data support the hypothesis that fibrosis in scleroderma may result in part from the activity of an inherently high procollagen-producing subset of normal fibroblasts that is expanded through exposure to immune cytokines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194462     DOI: 10.1002/art.1780330611

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis.

Authors:  Camilo S Zurita-Salinas; Edgar Krötzsch; Lino Díaz de León; Jorge Alcocer-Varela
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

2.  The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis.

Authors:  Aşkin Ateş; Gülay Kinikli; Murat Turgay; Murat Duman
Journal:  Clin Rheumatol       Date:  2004-05-15       Impact factor: 2.980

3.  Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture.

Authors:  F H van den Hoogen; P M van der Kraan; A M Boerbooms; W B van den Berg; H J van Lier; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

4.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.